Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 2/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | AXL | P30530 | 2/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | ETV6 | P41212 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4771101 | 0.96 | HRH3 (0.44) | HRH3POLBAXLROCK1TP53 | |
| Trifluoroacetic Acid SCHEMBL4764992 | 0.89 | TP53 (0.51) | SLC2A1HRH3ROCK1TP53SMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL4765302 | 0.88 | AXL (0.42) | SLC2A1HRH3AXLTP53CYP2D6 | |
| SCHEMBL4765386 | 0.85 | TP53 (0.55) | HRH3TP53SMN1; SMN2NPC1GAA | |
| Trifluoroacetic Acid SCHEMBL4771967 | 0.82 | SLC2A1 (0.45) | SLC2A1HRH3TP53CYP2D6HRH1 | |
| SCHEMBL4765254 | 0.82 | AXL (0.43) | HRH3AXLTP53CYP2D6HRH1 | |
| Trifluoroacetic Acid SCHEMBL4774586 | 0.81 | MAPT (0.51) | SLC2A1HRH3POLBAXLSMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL4775487 | 0.81 | KMT2A (0.53) | SLC2A1 | |
| Trifluoroacetic Acid SCHEMBL4768481 | 0.81 | NPY5R (0.49) | SLC2A1HRH3 | |
| SCHEMBL4771970 | 0.80 | HRH3 (0.40) | SLC2A1HRH3TP53CYP2D6HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1713778-B1 | BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS | GLAXO GROUP LTD (GB) | 2008-01-16 | — | — | EP | claimed |
| US-20070060566-A1 | Benzazepine derivatives as histamine h3 antagonists | GLAXO GROUP LIMITED (GB) | 2007-03-15 | — | — | US | claimed |
| EP-1713778-B1 | BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS | GLAXO GROUP LTD (GB) | 2008-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060566-A1 | Benzazepine derivatives as histamine h3 antagonists | HRH3, HRH4, HRH1 | SLC2A1 4665/4885HRH3 1/4885POLB 4330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.